Skip to main content

TSHA

Taysha Gene Therapies, Inc.

Company with tickers: TSHA

Market Cap
$1.99B
Shares Outstanding
287,361,020
CIK
1806310
CUSIP
877619106
13F Activity (30d)
2 filings 1 filers

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-04-10 Nagendran Sukumar 200,000
2026-02-27 Rumana Haque-Ahmed 2,405
2026-02-04 Kamran Alam 1,655
2026-02-04 Sean McAuliffe 914
2026-02-04 Emily McGinnis 901
2026-02-04 Rumana Haque-Ahmed 697
2026-02-04 Fred Porter 889
2026-01-23 Sean McAuliffe 46,064
2026-01-23 Kamran Alam 100,846
2026-01-23 Rumana Haque-Ahmed 30,052
2026-01-23 Sean P. Nolan 168,078
2026-01-23 Fred Porter 54,916
2026-01-23 Emily McGinnis 32,077
2026-01-23 Sukumar Nagendran 113,824
2026-01-12 Nagendran Sukumar 200,000
2025-11-28 Nagendran Sukumar 370,172
2025-09-22 Rumana Haque-Ahmed 10,770
2025-09-10 Nagendran Sukumar 200,000
2025-08-21 Fred Porter 50,451
2025-08-21 Sukumar Nagendran 57,054
2025-08-21 Kamran Alam 54,491
2025-08-21 Emily McGinnis 19,604
2025-08-21 Sean McAuliffe 27,590
2024-07-05 McGinnis Emily 16,869
2024-07-05 McAuliffe Sean 25,505
2024-07-05 Porter Fred 33,335
2023-08-24 Kamran Alam 33,000
2023-06-20 R.A. Sessions II 1,006,000
2023-06-01 McAuliffe Sean 21,305
2023-06-01 Porter Fred 42,491
2023-05-11 McGinnis Emily 19,784
Showing 1–31 of 31 filings